Keywords: chmp, recommends, approval, avastin, nsclc, swiss, drug

CHMP recommends approval of Avastin for NSCLC

Article | 30 July 2007

Swiss drug major Roche says that Avastin (bevacizumab), its anticancer agent, is the subject of a positive approval recommendation from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in